Patricia J. Zettler, associate professor of law, served as a consultant to the National Academies of Sciences, Engineering, and Medicine (NASEM) Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. The report, which was commissioned by the U.S. Food and Drug Administration (FDA), was released in July. Zettler has expertise in the regulation… more »
With the Food and Drug Administration’s approval of the first biosimilar (i.e., “generic” biologic drug) in March 2015, the job of journalists covering the drug industry and the FDA got a little harder. After that decision, they had to understand how the FDA’s regulation of biosimilars differs from that of traditional pharmaceuticals and biologic… more »
Associate professor of law Patricia J. Zettler brings her expertise in the regulation of medicine, biotechnology and biomedical research to the College of Law.
Lytton Applies Interdisciplinary Expertise to Teaching
Distinguished University Professor and Professor of Law Timothy D. Lytton has a longstanding interest in the public policy implications… more »
The Center for Law, Health and Society at Georgia State University welcomes two new faculty members with expertise in regulatory science: Timothy D. Lytton and Patricia J. Zettler.
The Food and Drug Administration defines regulatory science as “the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of… more »
Associate professor Patricia Zettler was named a 2015 Health Law Scholar at the American Society of Law, Medicine & Ethics’ 2015 Health Law Professors Conference hosted at Saint Louis University School of Law. As one of four professors selected nationwide, Zettler will participate in the Health Law Scholars Workshop, a joint initiative of SLU… more »
